- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Hong Kong Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
5
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
5 companies
RemeGen
Market Cap: HK$32.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$46.00
7D
-4.6%
1Y
79.0%
Akeso
Market Cap: HK$73.8b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$82.25
7D
-1.8%
1Y
102.3%
Ocumension Therapeutics
Market Cap: HK$6.2b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$7.66
7D
0%
1Y
13.1%
Ascentage Pharma Group International
Market Cap: HK$19.0b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$55.40
7D
10.5%
1Y
166.3%
CanSino Biologics
Market Cap: HK$12.0b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$34.60
7D
2.4%
1Y
59.4%